Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)
Medis Pharma Pty Ltd
rizatriptan benzoate
Tablet, orally disintegrating
Excipient Ingredients: aspartame; microcrystalline cellulose; colloidal anhydrous silica; crospovidone; magnesium stearate; mannitol; calcium silicate; Flavour
Oral
3, 2, 6
(S4) Prescription Only Medicine
RIZATRIPTAN-MEDIS is indicated for the acute treatment of migraine attacks with or without aura.
Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 10" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2015-02-19